cognitive cybersecurity intelligence

News and Analysis

Search

FDA Issues Alert to Mitigate Risks to a Widely Used Allergy, Nausea Drug

The US Food and Drug Administration (FDA) has issued new guidelines recommending the intramuscular injection of generic drug promethazine hydrochloride, reducing the risk of severe chemical irritation and tissue damage. The medicine is used to manage allergic reactions, motion sickness and post-operative nausea and vomiting.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts